OHSU

IRB #

IRB00007404

Title

PVAMC / OHSU: S0931 EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study

Principal Investigator

Christopher Ryan

Study Purpose

The purpose of this study is to see whether treatment with a drug called everolimus after surgery for kidney cancer will increase the time without cancer returning.

Medical Condition(s)

Kidney

Eligibility Criteria

* Subjects must be 18 years of age or older.
* Subjects must have a confirmed diagnosis of kidney cancer and prior surgery to remove cancer.
* Subject must not have prior anti-cancer treatment expect for a full or partial surgical removal of the affected kidney(s).
* Subject's medical history will be reviewed in detail for study eligibility.

Age Range

18 - 100

Healthy Volunteers Needed

No

Duration of Participation

Up to 10 years.

Minors Included

No

Contact

Clinical Trials Information Line: Phone 503-494-1080 or trials@ohsu.edu

Sponsor

SWOG

Recruitment End

Compensation Provided

No


Go Back